HPV Screening Rollout Across 1,200 GP Practices

The move to HPV primary screening changed how cervical screening samples were processed and reported. It was not a technology deployment with a clinical edge to it — it was a change to a national screening pathway, and roughly 1,200 GP practices had to move onto it without the service stopping.

Understanding what the programme actually was

The work needed coordination across GP practices, pathology laboratories, screening coordinators and national programme teams, all at once. I led the programme planning: scope, phasing, dependencies and the success criteria a rollout of this scale needs before it starts, with continuity of the screening service treated as a fixed constraint rather than an aspiration.

Deploying across 1,200 practices

Every practice ran its own clinical system configuration, local workflows and staffing constraints. A single deployment approach would have failed on contact with that variety, so the methodology was built around it:

• Pre-deployment readiness checks — each practice’s system version, connectivity and configuration assessed before deployment was scheduled, so failed installations were prevented rather than handled.
• Automated deployment tooling — scripted where possible, for consistency and to cut down on-site engineering visits.
• Regional phasing — practices grouped geographically so support coverage was efficient and go-live activity could be coordinated.

Integrating with the laboratories

The new pathway required integration between GP practice systems and pathology laboratory information management systems. I coordinated the technical work to make sample tracking, result reporting and failsafe mechanisms operate correctly end to end — validating message formats, testing the full data flow, and working with laboratory teams so their systems handled the new sample types and reporting requirements.

Training and change

Clinical and administrative staff across 1,200 practices needed to understand both why the change was being made and what it meant for their day. The training programme combined online resources with targeted face-to-face sessions for key staff, with materials developed alongside clinical leads so they were accurate and relevant. A network of regional champions provided peer support once the initial training had passed.

Support through the transition

Keeping the screening service running was non-negotiable. Each deployment phase had enhanced support arrangements: dedicated helpdesk resource, rapid escalation, and on-call technical support during go-live. Issues were tracked centrally and categorised by severity, which meant systemic problems were visible quickly and could be fixed across the estate rather than practice by practice — the difference between resolving one problem 1,200 times and resolving it once.

Quality assurance

Screening programmes run inside a strict quality assurance framework, and any disruption to accuracy or timeliness carries patient safety implications. I implemented QA checkpoints throughout: post-deployment validation of result reporting accuracy, monitoring of screening turnaround times, and regular reporting to the national programme team.

What changed

The transition to the new screening pathway completed across the estate with service continuity maintained and compliance with national screening standards held throughout — no degradation in screening service quality at any point in the rollout.